Brands: Doryx Mpc · Doxycycline Hyclate
Average across 13 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Alembic Pharmaceuticals Limited | generic | 28 | SUPPLYING |
| Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | generic | 10 | SUPPLYING |
| Solco Healthcare US, LLC | unknown | 7 | SUPPLYING |
| Mayne Pharma Commercial LLC | unknown | 4 | SUPPLYING |
| Sonoma Pharmaceuticals, Inc. | unknown | 1 | SUPPLYING |
| Actavis Pharma, Inc. | generic | 2 | EXITED 2027 |
Shortages, recalls, and registration changes attached to this drug concept.
Doxycycline Hyclate Tablet, Delayed Release — reported in shortage by Teva Pharmaceuticals USA, Inc.. Therapeutic category: Anti-Infective.
Doxycycline Hyclate Tablet, Delayed Release — reported in shortage by Teva Pharmaceuticals USA, Inc.. Therapeutic category: Anti-Infective.
